ROSHUNDIA MCKENZIE: Open Payments
NPI 1700190592 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 23 payments from 6 companies in 2025. Trend: 2023 $819 · 2024 $727 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $178 |
| E.R. Squibb & Sons, L.L.C. | 7 | $159 |
| Alkermes, Inc. | 4 | $118 |
| Otsuka America Pharmaceutical, Inc. | 2 | $53 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: INVEGA SUSTENNA, COBENFY, ARISTADA, ABILIFY MAINTENA, LYBALVI, INGREZZA, UZEDY.
Industry payments across MS — which companies pay providers there.
